Enanta Pharmaceuticals, Inc.

NASDAQ:ENTA

10.95 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q4
Revenue 17.97117.05418.00318.93218.89217.79523.58520.31719.47918.71627.64823.57521.62420.13231.74323.63118.65327.61952.5751.31344.36739.63169.88667.20557.26244.04938.10975.9277.5118.95910.41712.84113.97813.00448.44514.41611.59957.36777.4982.63742.0512.160.8931.3491.6491.19627.8591.8582.54236.5650.7410
Cost of Revenue 0.5940.6210.6420.6690.6510.540.5110.6550.7160000000000000000000000000000000000000000000
Gross Profit 17.37716.43317.36118.26318.24117.25523.07419.66218.76318.71627.64823.57521.62420.13231.74323.63118.65327.61952.5751.31344.36739.63169.88667.20557.26244.04938.10975.9277.5118.95910.41712.84113.97813.00448.44514.41611.59957.36777.4982.63742.0512.160.8931.3491.6491.19627.8591.8582.54236.5650.7410
Gross Profit Ratio 0.9670.9640.9640.9650.9660.970.9780.9680.9631111111111111111111111111111111111111111110
Reseach & Development Expenses 28.74235.58536.37136.16742.98743.46840.90234.79639.0942.08748.54948.94646.99441.50636.66536.68634.68232.6132.77838.71934.46134.15534.87826.92328.48721.48417.96216.51415.40713.00412.52611.510.7859.1439.0337.0496.2535.3684.5195.2024.5534.7224.2634.34.0393.8554.7984.2554.9253.2632.6722.929
General & Administrative Expenses 13.41414.23516.51813.79512.61813.77812.69612.56912.92910.4769.5088.3568.4778.3267.3776.7286.8236.8846.9216.1636.1516.787.1525.836.1355.7065.775.1185.2335.4614.9374.444.2824.4263.8183.6933.6433.4382.7692.7612.6032.5652.0871.751.7881.3421.1521.6991.1451.2071.2510
Selling & Marketing Expenses -0.59400000000000000000000000000000000000000000000000.0730000
SG&A 12.8214.23516.51813.79512.61813.77812.69612.56912.92910.4769.5088.3568.4778.3267.3776.7286.8236.8846.9216.1636.1516.787.1525.836.1355.7065.775.1185.2335.4614.9374.444.2824.4263.8183.6933.6433.4382.7692.7612.6032.5652.0871.751.7881.3421.1521.7721.1451.2071.2511.202
Other Expenses 000-4.6991.8691.8370.99300.3930.2550.2580.3330.4390.5450.6771.1491.4451.952.0762.2742.4152.2451.8851.4291.3381.0660.960.660.600.5240.471000.3290.5090.2870.210.3010.2360000.25800000000
Operating Expenses 41.56249.8252.88949.96255.60557.24653.59847.36552.01952.56358.05757.30255.47149.83244.04243.41441.50539.49439.69944.88240.61240.93542.0332.75334.62227.1923.73221.63220.6418.46517.46315.9415.06713.56912.85110.7429.8968.8067.2887.9637.1567.2876.356.055.8275.1975.956.0276.074.473.9234.131
Operating Income -24.185-32.766-34.886-31.03-36.713-39.451-30.013-27.048-32.54-33.847-30.409-33.727-33.847-29.7-12.299-19.783-22.852-11.87512.8716.4313.755-1.30427.85634.45222.6416.85914.37754.295-13.129-9.506-7.046-3.099-1.089-0.56535.5943.6741.70348.56170.21-5.32634.895-5.127-5.457-4.701-4.178-4.00121.909-4.169-3.52832.095-3.182-4.131
Operating Income Ratio -1.346-1.921-1.938-1.639-1.943-2.217-1.273-1.331-1.671-1.808-1.1-1.431-1.565-1.475-0.387-0.837-1.225-0.430.2450.1250.085-0.0330.3990.5130.3950.3830.3770.715-1.748-1.061-0.676-0.241-0.078-0.0430.7350.2550.1470.8460.906-2.020.83-2.374-6.111-3.485-2.534-3.3450.786-2.244-1.3880.878-4.2940
Total Other Income Expenses Net 1.1321.2460.8571.5131.8691.8370.9930.7140.3930.2550.2580.3330.4390.5450.6771.1491.4451.952.0762.2742.4152.2451.8851.4291.3381.0660.960.660.6-0.0150.5240.471-0.0160.0750.3290.5090.2870.210.3010.236-0.065-0.186-0.0170.258-0.0170.2140.020.076-0.0210.0010.0090.123
Income Before Tax -23.053-31.52-34.029-29.517-34.844-37.614-29.02-26.334-32.147-33.592-30.151-33.394-33.408-29.155-11.622-18.634-21.407-9.92514.9478.7056.170.94129.74135.88123.97817.92515.33754.955-12.529-8.957-6.522-2.628-0.642-0.09335.9234.1831.9948.77170.511-5.0934.931-5.203-5.37-4.443-4.138-3.74921.957-4.052-3.50132.111-3.159-3.989
Income Before Tax Ratio -1.283-1.848-1.89-1.559-1.844-2.114-1.23-1.296-1.65-1.795-1.091-1.417-1.545-1.448-0.366-0.789-1.148-0.3590.2840.170.1390.0240.4260.5340.4190.4070.4020.724-1.668-1-0.626-0.205-0.046-0.0070.7420.290.1720.850.91-1.930.831-2.409-6.013-3.294-2.509-3.1350.788-2.181-1.3770.878-4.2630
Income Tax Expense -0.395-0.363-0.622-1.414.2210.044-0.0340.014-0.447-0.255-0.036-8.795-9.384-7.11-3.29410.707-7.142-3.921.504-0.486-0.866-3.2043.738.4613.695.373.64418.447-4.103-3.565-1.542-0.8260.4341.5529.734-1.629-0.42820.01828.502-0.048-15.1220.0040.005-0.0730.007-0.0390.00700000
Net Income -22.658-31.157-33.407-28.107-39.065-37.658-28.986-26.348-31.7-33.337-30.115-24.599-24.024-22.045-8.328-29.341-14.265-6.00513.4439.1917.0364.14526.01127.4220.28812.55511.69336.508-8.426-5.392-4.98-1.802-1.076-1.64526.1895.8122.41828.75342.009-5.04250.053-5.203-5.37-4.443-4.138-3.74921.957-4.052-3.50132.111-3.159-3.989
Net Income Ratio -1.261-1.827-1.856-1.485-2.068-2.116-1.229-1.297-1.627-1.781-1.089-1.043-1.111-1.095-0.262-1.242-0.765-0.2170.2560.1790.1590.1050.3720.4080.3540.2850.3070.481-1.122-0.602-0.478-0.14-0.077-0.1260.5410.4030.2080.5010.542-1.9121.19-2.409-6.013-3.294-2.509-3.1350.788-2.181-1.3770.878-4.2630
EPS -1.07-1.47-1.58-1.33-1.86-1.79-1.39-1.28-1.53-1.62-1.48-1.22-1.19-1.09-0.41-1.46-0.71-0.30.680.470.360.211.341.411.050.650.611.91-0.44-0.28-0.26-0.095-0.057-0.091.390.30.131.542.26-0.272.7-0.28-0.3-0.25-0.23-1.711.61-3.59-3.022.27-0.25-0.31
EPS Diluted -1.07-1.47-1.58-1.33-1.86-1.79-1.39-1.28-1.53-1.62-1.48-1.22-1.19-1.09-0.41-1.46-0.71-0.30.650.440.330.21.251.30.970.610.591.86-0.44-0.28-0.26-0.095-0.057-0.0871.360.290.131.492.18-0.272.61-0.28-0.3-0.25-0.23-1.711.45-3.5-1.331-0.22-0.31
EBITDA -23.591-32.766-29.946-25.697-36.713-39.451-30.013-26.393-31.824-33.025-30.409-33.727-33.847-29.7-12.299-19.783-22.852-11.87512.8716.4313.755-1.30427.85634.45222.6416.85914.37754.295-13.129-8.406-7.046-3.099-0.1810.27635.5943.6741.70348.56170.21-5.32635.089-4.934-5.273-4.701-4.053-3.95421.983-4.089-3.44532.152-3.112-3.99
EBITDA Ratio -1.313-1.921-1.663-1.357-1.943-2.217-1.273-1.299-1.634-1.765-1.1-1.431-1.565-1.475-0.387-0.837-1.225-0.430.2450.1250.085-0.0330.3990.5130.3950.3830.3770.715-1.748-0.938-0.676-0.241-0.0130.0210.7350.2550.1470.8460.906-2.020.834-2.284-5.905-3.485-2.458-3.3060.789-2.201-1.3550.879-4.20